Houser Brandy

HEAD
IMMUNOLOGY
Celdara Medical
United States of America

Biography

Brandy Houser, Ph.D. received her Ph.D. in immunology from Harvard University under the guidance of Dr. Jack Strominger for the discovery of specialized macrophage subsets at the human maternal-fetal interface. During her graduate career she was a commercialization fellow at Harvard Medical School. Following her graduate studies, Brandy was the Alliance Manager for Partners Healthcare, the corporate entity that oversees operations for the Massachusetts General Hospital and the Brigham and Women’s Hospital. During this time she managed technologies from both hospitals as well as programs for Pfizer’s Center for Therapeutics. She also helped to create the business and operations plan for The Human Translational Immunology Center at the Brigham and Women’s Hospital. Most recently, Brandy was an Investment Associate at Brandon Capital Partners, an Australian venture capital firm. At Celdara Medical, she is responsible for operations of the New York/New Jersey office, as well as sourcing and vetting new pipeline assets. Brandy Houser, Ph.D. received her Ph.D. in immunology from Harvard University under the guidance of Dr. Jack Strominger for the discovery of specialized macrophage subsets at the human maternal-fetal interface. During her graduate career she was a commercialization fellow at Harvard Medical School. Following her graduate studies, Brandy was the Alliance Manager for Partners Healthcare, the corporate entity that oversees operations for the Massachusetts General Hospital and the Brigham and Women’s Hospital. During this time she managed technologies from both hospitals as well as programs for Pfizer’s Center for Therapeutics. She also helped to create the business and operations plan for The Human Translational Immunology Center at the Brigham and Women’s Hospital. Most recently, Brandy was an Investment Associate at Brandon Capital Partners, an Australian venture capital firm. At Celdara Medical, she is responsible for operations of the New York/New Jersey office, as well as sourcing and vetting new pipeline assets.

Research Intrest

 THERAPEUTICS